In New York, colorectal cancer is a top cause of cancer deaths across all populations. While screening rates have improved, ...

Optimal stopping ages for colorectal cancer (CRC) screening depend on sex, comorbidity, and prior screening history, affecting cost-effectiveness and clinical outcomes. The MISCAN-Colon model ...

The findings reveal that in triaging FIT-positive patients in CRC screening, the QuantiDNA™ test from patients' plasma reduces the need for colonoscopy examinations by 33% and is non-inferior to ...

In July, the FDA approved Guardant Health’s Shield, the first blood test approved as a primary CRC screening option. It joins the pipeline of noninvasive screening tests such as fecal ...

“Despite compelling evidence that CRC screening reduces CRC mortality, screening is severely underused in federally qualified health centers (FQHCs), which serve more than 30 million low-income ...

Investors in California Resources Corp (Symbol: CRC) saw new options begin trading this week, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Participants were males and females, 50 years and above, with no prior history of CRC screening ... needed to carefully consider all response options before describing experiences.

Below is a chart showing KRYS's trailing twelve month trading history, with the $170 strike highlighted in orange: And California Resources Corp (Symbol: CRC) options are showing a volume of 4,828 ...

A RECENT trial has shown that a centralised, mailed colorectal cancer (CRC) screening programme significantly improved screening completion rates in federally qualified health centres (FQHCs) serving ...